TMEM70
Basic information
Region (hg38): 8:73972437-73982783
Links
Phenotypes
GenCC
Source:
- mitochondrial complex V (ATP synthase) deficiency nuclear type 2 (Definitive), mode of inheritance: AR
- mitochondrial complex V (ATP synthase) deficiency nuclear type 2 (Strong), mode of inheritance: AR
- mitochondrial complex V (ATP synthase) deficiency nuclear type 2 (Supportive), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Cardiovascular; Craniofacial; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic | 18953340; 21147908; 24485043 |
ClinVar
This is a list of variants' phenotypes submitted to
- Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 (14 variants)
- not provided (3 variants)
- Mitochondrial proton-transporting ATP synthase complex deficiency (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TMEM70 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 61 | 66 | ||||
missense | 111 | 121 | ||||
nonsense | 7 | |||||
start loss | 1 | |||||
frameshift | 11 | 15 | ||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 2 | 4 | 6 | |||
non coding | 26 | 24 | 19 | 69 | ||
Total | 15 | 9 | 149 | 87 | 25 |
Highest pathogenic variant AF is 0.0000132
Variants in TMEM70
This is a list of pathogenic ClinVar variants found in the TMEM70 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-73975814-T-C | Benign (Jun 14, 2018) | |||
8-73975891-T-A | Likely benign (Jul 07, 2018) | |||
8-73976018-C-A | Likely benign (Jun 14, 2018) | |||
8-73976049-AGGCGGCAGGCG-A | Likely benign (Jun 26, 2018) | |||
8-73976049-AGGCGGCAGGCGGGCGGCAGGCG-A | Likely benign (Jun 16, 2018) | |||
8-73976049-AGGCGGCAGGCGGGCGGCAGGCGGGCGGCAGGCGGGCGGCAGGCGGGCGGCAGGCG-A | Benign (Jun 23, 2018) | |||
8-73976049-A-AGGCGGCAGGCGGGCGGCAGGCGGGCGGCAGGCG | Likely benign (May 26, 2021) | |||
8-73976049-A-AGGCGGCAGGCGGGCGGCAGGCG | Benign (Sep 09, 2019) | |||
8-73976187-C-T | Mitochondrial proton-transporting ATP synthase complex deficiency | Uncertain significance (Jun 14, 2016) | ||
8-73976203-G-GGCAGTCGGGTGGGAAGCCGTGTCTC | not specified | Likely benign (May 23, 2017) | ||
8-73976229-G-A | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Benign/Likely benign (Jul 15, 2018) | ||
8-73976243-G-A | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Uncertain significance (Jan 12, 2018) | ||
8-73976243-G-T | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Uncertain significance (Jan 13, 2018) | ||
8-73976259-C-T | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Benign (Jan 12, 2018) | ||
8-73976267-C-G | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Uncertain significance (Jan 13, 2018) | ||
8-73976269-C-A | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Uncertain significance (Apr 27, 2017) | ||
8-73976283-T-C | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Likely pathogenic (Aug 22, 2019) | ||
8-73976287-G-C | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Likely benign (Aug 09, 2022) | ||
8-73976291-C-G | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Uncertain significance (Jan 24, 2024) | ||
8-73976292-T-G | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Uncertain significance (Jun 30, 2021) | ||
8-73976297-T-C | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Likely benign (Feb 25, 2023) | ||
8-73976303-AG-CC | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Uncertain significance (Aug 05, 2022) | ||
8-73976305-C-A | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Uncertain significance (Oct 03, 2022) | ||
8-73976306-C-T | not specified • Inborn genetic diseases | Conflicting classifications of pathogenicity (Aug 14, 2023) | ||
8-73976307-C-T | Mitochondrial complex V (ATP synthase) deficiency nuclear type 2 | Uncertain significance (May 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TMEM70 | protein_coding | protein_coding | ENST00000312184 | 3 | 10347 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0293 | 0.928 | 125709 | 0 | 35 | 125744 | 0.000139 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.129 | 139 | 143 | 0.970 | 0.00000724 | 1652 |
Missense in Polyphen | 33 | 41.227 | 0.80046 | 496 | ||
Synonymous | -0.552 | 65 | 59.6 | 1.09 | 0.00000297 | 547 |
Loss of Function | 1.75 | 4 | 9.95 | 0.402 | 6.48e-7 | 98 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000289 | 0.000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000328 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in biogenesis of mitochondrial ATP synthase. {ECO:0000269|PubMed:18953340, ECO:0000269|PubMed:20937241}.;
- Disease
- DISEASE: Mitochondrial complex V deficiency, nuclear 2 (MC5DN2) [MIM:614052]: A mitochondrial disorder with heterogeneous clinical manifestations including dysmorphic features, psychomotor retardation, hypotonia, growth retardation, cardiomyopathy, enlarged liver, hypoplastic kidneys and elevated lactate levels in urine, plasma and cerebrospinal fluid. {ECO:0000269|PubMed:18953340, ECO:0000269|PubMed:22986587}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0543
Intolerance Scores
- loftool
- 0.696
- rvis_EVS
- 1.06
- rvis_percentile_EVS
- 91.51
Haploinsufficiency Scores
- pHI
- 0.0374
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.437
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.131
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tmem70
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- mitochondrial proton-transporting ATP synthase complex assembly
- Cellular component
- nucleoplasm;mitochondrion;mitochondrial inner membrane;integral component of mitochondrial membrane
- Molecular function
- molecular_function